[
  {
    "ts": null,
    "headline": "Is CVS Health Corporation (CVS) the Best Performing Healthcare Stock to Buy Now?",
    "summary": "We recently published a list of 11 Best Performing Healthcare Stocks to Buy Now. In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands against other best performing healthcare stocks to buy now. Trump’s Healthcare Executive Order Brings a Win On April 15, CNBC reported that President Trump’s […]",
    "url": "https://finnhub.io/api/news?id=1c16592e7c7baf28d3ca6138840c1fece52d67e85916bee74e52febcd99e0e44",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746998637,
      "headline": "Is CVS Health Corporation (CVS) the Best Performing Healthcare Stock to Buy Now?",
      "id": 134379520,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "We recently published a list of 11 Best Performing Healthcare Stocks to Buy Now. In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands against other best performing healthcare stocks to buy now. Trump’s Healthcare Executive Order Brings a Win On April 15, CNBC reported that President Trump’s […]",
      "url": "https://finnhub.io/api/news?id=1c16592e7c7baf28d3ca6138840c1fece52d67e85916bee74e52febcd99e0e44"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health: Big 2025 Momentum, Strong Growth Ahead, Shares Underpriced",
    "summary": "CVS Health shows strong growth with strategic shifts, improved Medicare ratings, and promising earnings. Read why I see CVS stock targeting $83 this year.",
    "url": "https://finnhub.io/api/news?id=f194a52623da0a40d67100fcaab14a19444cd13b07b5746e57df62620d0beb90",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746994761,
      "headline": "CVS Health: Big 2025 Momentum, Strong Growth Ahead, Shares Underpriced",
      "id": 134373583,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1401250676/image_1401250676.jpg?io=getty-c-w1536",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "CVS Health shows strong growth with strategic shifts, improved Medicare ratings, and promising earnings. Read why I see CVS stock targeting $83 this year.",
      "url": "https://finnhub.io/api/news?id=f194a52623da0a40d67100fcaab14a19444cd13b07b5746e57df62620d0beb90"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health: Firing On All Cylinders, Thanks To The Promising Reversal",
    "summary": "Discover why CVS' turnaround may be underway with improved medical cost trends, segment growth, and raised FY2025 guidance.",
    "url": "https://finnhub.io/api/news?id=b01e7c818623d7de39b7dcbdaf0a6b2b364873dc1baae3d7a916bbbe25f521fe",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746961331,
      "headline": "CVS Health: Firing On All Cylinders, Thanks To The Promising Reversal",
      "id": 134371514,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2196106798/image_2196106798.jpg?io=getty-c-w1536",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "Discover why CVS' turnaround may be underway with improved medical cost trends, segment growth, and raised FY2025 guidance.",
      "url": "https://finnhub.io/api/news?id=b01e7c818623d7de39b7dcbdaf0a6b2b364873dc1baae3d7a916bbbe25f521fe"
    }
  },
  {
    "ts": null,
    "headline": "Invesco Comstock Fund Q1 2025 Commentary",
    "summary": "The largest contributors to relative return were consumer staples, health care and consumer discretionary, primarily due to stock selection. Read more here.",
    "url": "https://finnhub.io/api/news?id=8da8af5dd59ec4a391f82f52f04fc463362fb0b42c3e978a812a88b87697e4ba",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746953700,
      "headline": "Invesco Comstock Fund Q1 2025 Commentary",
      "id": 134370892,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1390682333/image_1390682333.jpg?io=getty-c-w1536",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "The largest contributors to relative return were consumer staples, health care and consumer discretionary, primarily due to stock selection. Read more here.",
      "url": "https://finnhub.io/api/news?id=8da8af5dd59ec4a391f82f52f04fc463362fb0b42c3e978a812a88b87697e4ba"
    }
  },
  {
    "ts": null,
    "headline": "Invesco Equally-Weighted S&P 500 Fund Q1 2025 Commentary",
    "summary": "The fundâs underweights and stock selection in the information technology and consumer discretionary sectors had the largest positive effects on relative return.",
    "url": "https://finnhub.io/api/news?id=9384f087f2f2e4fe60bbe17fcf10ab4e24ff1c44d485209670a64ee1757b0ce3",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746945660,
      "headline": "Invesco Equally-Weighted S&P 500 Fund Q1 2025 Commentary",
      "id": 134370428,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1617910856/image_1617910856.jpg?io=getty-c-w1536",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "The fundâs underweights and stock selection in the information technology and consumer discretionary sectors had the largest positive effects on relative return.",
      "url": "https://finnhub.io/api/news?id=9384f087f2f2e4fe60bbe17fcf10ab4e24ff1c44d485209670a64ee1757b0ce3"
    }
  },
  {
    "ts": null,
    "headline": "3 Ideal Buys From 63 May Fortune 500 Industry Leaders",
    "summary": "The June/July 2024 Fortune Magazine revealed 500 biggest US companies by-revenue and profits. Check out three safer F500ILs emerged as safer buys for May.",
    "url": "https://finnhub.io/api/news?id=f4a32a6c5c340b47b0a6caaa9d214a1b8fd2230eec8c69aa6c43d80424d19d4f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746939801,
      "headline": "3 Ideal Buys From 63 May Fortune 500 Industry Leaders",
      "id": 134369997,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1385706512/image_1385706512.jpg?io=getty-c-w1536",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "The June/July 2024 Fortune Magazine revealed 500 biggest US companies by-revenue and profits. Check out three safer F500ILs emerged as safer buys for May.",
      "url": "https://finnhub.io/api/news?id=f4a32a6c5c340b47b0a6caaa9d214a1b8fd2230eec8c69aa6c43d80424d19d4f"
    }
  },
  {
    "ts": null,
    "headline": "Invesco Growth And Income Fund Q1 2025 Commentary",
    "summary": "Reversing a trend in Q4, value stocks outperformed growth in Q1 as the Russell 1000 Value Index returned 2.14% and the Russell 1000 Growth Index returned -9.97%.",
    "url": "https://finnhub.io/api/news?id=fcae6f6024509d9d4f9f06b8c6c1d0ac7a49a3bf5bce221e086f90a6b578e022",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746937620,
      "headline": "Invesco Growth And Income Fund Q1 2025 Commentary",
      "id": 134369791,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2160994971/image_2160994971.jpg?io=getty-c-w1536",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "Reversing a trend in Q4, value stocks outperformed growth in Q1 as the Russell 1000 Value Index returned 2.14% and the Russell 1000 Growth Index returned -9.97%.",
      "url": "https://finnhub.io/api/news?id=fcae6f6024509d9d4f9f06b8c6c1d0ac7a49a3bf5bce221e086f90a6b578e022"
    }
  }
]